Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New feature:   Automatically detect candlestick patterns on any chart

Read How
Market News Market Pulse Stocks News ETF News Crypto News

20/20 Biolabs Inc.

Contributing Author

Recent Articles by 20/20 Biolabs Inc.

Aug-28
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest Revenue and Expanding Commercial Opportunity AIDX GlobeNewswire
Aug-26
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest Revenue and Expanding Commercial Opportunity AIDX +6.59% GlobeNewswire
Aug-17
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level AIDX GlobeNewswire
Jul-30
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management's Recent East Asia Business Development Tour AIDX -8.49% GlobeNewswire
Jul-27
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy AIDX -8.31% GlobeNewswire
Jul-23
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock AIDX -6.76% GlobeNewswire
Jul-09
20/20 BioLabs Highlights Investor Webinar Focused on OneTest for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth AIDX GlobeNewswire
Jun-22
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month AIDX -6.85% GlobeNewswire
May-27
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters AIDX GlobeNewswire
May-22
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand AIDX -18.67% GlobeNewswire
May-20
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress AIDX AIDX -6.59% GlobeNewswire
May-14
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 AIDX GlobeNewswire
May-12
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina AIDX +6.33% GlobeNewswire
Apr-07
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest for Cancer Through Evexia Platform AIDX -5.45% GlobeNewswire
Mar-31
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress AIDX +5.62% GlobeNewswire
Mar-27
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test AIDX GlobeNewswire
Mar-24
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program AIDX -17.59% GlobeNewswire
Mar-12
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies AIDX -8.49% GlobeNewswire
Feb-25
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities AIDX -28.82% GlobeNewswire
Feb-20
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time AIDX -38.04% GlobeNewswire
Feb-19
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth AIDX GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)